Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.030
-0.090 (-4.25%)
Oct 31, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Next-generation Cell and Gene Therapies
2.56M
Log In
Log In
Next-generation Cell and Gene Therapies Growth
-40.25%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
2.56M
Log In
Log In
United States Growth
-40.25%
Log In
Log In